Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accent Microcell is a leading Indian manufacturer of high-quality cellulose-based excipients, primarily specializing in Microcrystalline Cellulose (MCC). The company serves a diverse global clientele across the pharmaceutical, nutraceutical, food, cosmetic, and chemical industries. With state-of-the-art manufacturing facilities in Gujarat, they produce various grades of MCC, carboxymethylcellulose, and other specialized excipients used as binders, disintegrants, and fillers in solid dosage formulations. Accent Microcell is recognized for its adherence to international quality standards, including WHO-GMP and ISO certifications. The company maintains a significant export presence, supplying products to over 45 countries worldwide. In December 2023, the company successfully transitioned to a public entity with its listing on the NSE SME platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accent Microcell.